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For the new ion beam facility in Wiener Neustadt, Austria, we are 
developing a new system which is capable of ultrafast in-room (in-
isocenter) imaging. The system integrates an independently moveable 
X-ray source and a flat panel with the positioning device. The couch 
itself and the patient are carried by an industrial six axes robot which 
is ceiling mounted. While the new imaging system offers flexible field 
of view very fast CBCT, fluoroscopy, simultaneous kV and MV imaging, 
rapid 2D/3D image registration and new dual energy options for 
increased soft tissue contrast, the robot allows corrections in six 
degrees of freedom, also in a tracking mode, in real time. The system 
is designed generically enough to be installed as a retro-fit upgrade in 
conventional linear accelerator bunkers in the future, and integrates 
imaging, positioning and adaptive treatment planning with the 
irradiation unit´s record and verify system. 
Additionally, we presented the first clinical release of an online, 
adaptive, aperture based IGRT protocol for IMRT of the prostate that 
works without re-positioning of the patient on a standard linear 
accelerator equipped with an integrated multi leaf collimator. This 
protocol is based on analysis of 4 gold marker positions in planar 
projection images and requires no pre-treatment CBCT acquisition. 
MLC leaf positions for all IMRT segments are adapted to the 
transformed PTV and rectum avoidance structure within seconds. 
For 31/39 patients, in 833/1013 fractions (supine, flat couch, knee 
support, comfortably full bladder, empty rectum, no intraprostatic 
marker migrations >2 mm of more than one marker), the online 
aperture adaption allowed safe reduction of margins CTV-PTV 
(prostate) down to 5 mm when only interfractional corrections were 
applied: Dominant L-R rotations were found to be 5.3° (mean of 
means), standarddeviation of means ±4.9°, maximum at 30.7°; 3D 
vector translations relative to skin markings were 9.3±4.4 mm (max. 
23.6 mm). Intra-fractional movements in 7.7±1.5 minutes (max. 15.1 
min) between kV imaging and last beam’s EPI showed further L-R 
rotations of 2.5°±2.3° (max. 26.9°), and 3D vector translations of 
3.0±3.7 mm (max. 10.2 mm). Addressing intra-fractional errors could 
further reduce margins down to 3 mm. 
A basic requirement for any robotic solution in the field is a fast 
image feedback loop. This means seamless integration of at least kV 
and MV imaging functionality into the treatment delivery application. 
Online strategies in adaptive IGRT do also require classical treatment 
planning features (e.g. image registration, handling of structure sets, 
MLC shape optimization) to be migrated from separate planning rooms 
towards the treatment unit and embedded in the record & verify 
systems - this was realized in the open source software framework 
open-radART, see www.open-radART.org 
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The development of Image guided and adaptive radiotherapy 
(IGRT/IGART) has brought new challenges to the work of radiotherapy 
departments worldwide. Challenges include changes in workflow, 
handling of new tasks, potentially increased treatment time at 
accelerators and resource management – all requiring optimisation 
while maintaining treatment quality of the individual patient. The 
recent introduction of IGRT, from 2D/2D IGRT to 3D volumetric IGRT 
based on cone-beam CT (CBCT), has revealed the need for adaptation. 
In the pelvic region inter-fractional changes are predominantly 
random, making plan selection strategies - from a library of pre-
planned treatment plans - the most obvious type of IGART. For other 
treatment sites such as head and neck and lung, where gradual 
changes such as weight loss and tumour shrinkage are dominating, 
adaptive re-planning during the course of RT seems to be more 
appropriate. In this presentation we will share our experience in 
implementation of IGRT using 2D/2D-images and later CBCT for nearly 
all treatments with curative intent, as well as our more recent 
experience with implementation of IGART for bladder cancer.  
IGRT was implemented in our whole department for most tumour sites 
treated with curative intent. During this process, all RTTs were 
educated in a Virtual training centre with 3D accelerator and an IT-
lab. Our first step was introduction of IGRT using orthogonal x-ray 
images, which was implemented in 2008. The next step was taken in 
2009, where IGRT using daily cone-beam CT (CBCT) was implemented, 
again department-wide and for all pelvic, head and neck, brain and 
thoracic treatment sites. IGRT implementation was done without 
extended time slots for each treatment, only a general daily IGRT 
‘buffer’ was scheduled in the implementation period at each 
accelerator. The time used for image registration evaluation and how 
it changed with increasing experience was analysed. Off-line check of 
the match was performed by either an oncologist or physicist. 
Online plan selection for bladder cancer has been implemented with a 
three-step training program. Step 1 was a four-session e-learning 
module including ‘ART in general’, ‘Image quality’, ‘Bladder cancer 
and anatomy’ and ‘Plan selection process’. Step 2 was a full day 
training seminar with presentations, 3D visualisation of patient 
anatomy and hands-on training in selection of the most appropriate 
treatment plan. Step 3 was half a day seminar including 
presentations, wrap-up, short hands-on and a test. The test was 
performed using retrospective data for eight bladder cancer patients 
with in total 196 CBCT’s. RTTs were working in teams of two, as they 
do in their daily routine. For each team 16 treatment fractions were 
randomly chosen.The concordance of the plan selections relative to 
expert selections was evaluated and the consequences of a wrong 
choice were assessed. Maximum deviations (i.e. bladder outside the 
selected plan) in the 6 directions was 6 mm Superior, 2 mm inferior, 1 
mm anterior, 5 mm posterior, 3 mm left and 3 mm right. The 
corresponding frequencies of treatment fractions with deviations were 
7%, 4%, 1%, 4%, 2% and 1%, respectively. Time used for the selection 
of treatment plan was mean 2 min: 10 sec (range 0:20; 5:31); this 
increase did not result in the need for increasing the time-slot for the 
plan selection treatment. Preliminary clinical plan selections as well 
as the resulting dose delivered will be presented. 
We have developed a concept for ‘Department wide’ implementation 
processes in IGRT and IGART, with successful image registration 
sresults, treatment times and plan selections. A comprehensive 
training programme for the RTTs is essential for a successful 
implementation of IGRT/IGART.  
  
 SYMPOSIUM: EMERGING TECHNOLOGIES IN PARTICLE 
THERAPY  
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The EBG MedAustron GmbH, a publically financed corporation, is 
establishing a centre for ion beam therapy and research, the 
MedAustron, in Wiener Neustadt in the county of Lower Austria. It is 
planned to treat fist patient at the end of 2015 and bring the centre 
to full capacity in 2020. The Medaustron building was constructed 
within18 months with the sandwich method that uses concrete panels 
between which the excavated soil is loosely placed and subsequently 
compacted to the density of concrete.  The used technology allowed 
saving 25000 cubic-meters of the concrete, 7500 tons of steel and 
shortening construction time by 6 months. 
The development of the equipment that will be installed and used at 
the MedAustron is performed within cooperation with several 
industrial and scientific partners. The MedAustron centre comprises an 
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accelerator facility based on a synchrotron for the delivery of protons 
and light ions to four irradiation rooms (IR) for cancer treatment and 
for clinical and non-clinical research. The planning and development 
of the accelerator facilities are performed in collaboration with the 
European Organization for Nuclear Research (CERN). For clinical 
purposes and non-clinical research (NCR), protons from 60 MeV to 250 
MeV and carbon ions from 120 MeV/u to 400 MeV/u will be used in 
four irradiation rooms (IR1 - IR4). The three rooms (IR2-IR4) will be 
used for clinical purposes. The separate room – IR1 is dedicated to 
NCR, where protons up to 800 MeV can be used. The first and the third 
IRs (IR1 and IR3) are equipped with a fixed horizontal beam line for 
carbon ions and protons. The second IR - IR2 is equipped with a 
horizontal and a vertical beam lines for carbon ions and protons. The 
fourth IR - IR4 features a proton gantry that allows irradiation from 
various angles. Based upon a license agreement with the Paul Scherrer 
Institute (PSI), Villigen, MedAustron further develops the technology 
of PSI Gantry 2 for the clinical application. All IRs will be equipped 
with the continuous scanning beam delivery systems that are 
developed in cooperation with CNAO Foundation, Pavia. 
Each irradiation room (IR2, IR3, IR4 and also NCR IR1) is equipped with 
a robotic patient alignment system (PAS). The development of PAS is 
performed within cooperation between MedAustron and Buck 
Engineering and Consulting, Germany and Paracelsus Medical 
University (PMU), Salzburg. The major components of the PAS consist 
of the ceiling-mounted robotic patient positioner, that can move in 
seven ways in order to select the ideal beam entrance angle of the ion 
beam; anti-collision system, and the 2D-3D patient position 
verification system (PPVS) with x-ray source, image capture device, 
anti-collision system and control and image processing software, with 
which the position of the patient is determined prior to irradiation 
and can be fine-tuned automatically. 
Comprehensive image, data and patient information management 
software that centralizes ion beam therapy process and is accessible 
by multi-disciplinary team across multiple locations will giving the 
flexibility to choose the optimal treatment solutions. The Institute for 
research and development on Advanced Radiation Technologies 
(radART) of the PMU has a scientific collaboration with the EBG 
MedAustron GmbH in the field of developing, integrating and 
commissioning an open source software suite for the MedAustron. A 
range of integrated medical software components - open-radART ion -
 will be integrated with the treatment planning software from 
Research Laboratories, Sweden. RayStation® will be used for planning 
of all treatments including both treatments with protons and carbon 
ions and for the conventional treatments as a back-up. The new 
carbon ion planning module builds on the current pencil beam 
scanning functionality for protons.The module will optimize the 
scanning pattern for discrete and line scanned beams.Characteristics 
of the beam delivery system, like dose rate and spot size, will also be 
subject for optimization. For physical dose calculation two algorithms 
are used, pencil beam and Monte Carlo, to serve both normal clinical 
use as well as research needs. The system will also be capable of 
optimizing biologically effective dose. 
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Proton and ion beams open up new vistas for the curative treatment 
of tumors, in particular in close proximity to organs of risk.  In 
contrast to gamma rays or electrons their energy deposition is well 
confined to a region defined by the particle range.  The dose 
distribution characterized by a distinct maximum (Bragg peak) and a 
sharp distal edge allows concentrating a high dose in the treatment 
volume while sparing healthy tissue, supposed the particle range is 
well under control.  Range verification by appropriate in-vivo 
measurements is the only way to avoid uncertainties caused by factors 
that cannot be assessed by established clinical workflows. 
Corresponding techniques have to be based on distinct signals, 
generated by and spatially correlated with the treatment beam, 
advantageously leaving the patient’s body with minimum 
interference. Such signals are gamma rays, fast neutrons, or fast 
charged particles originating from direct interactions of beam 
particles with nuclei of the tissue, as well as the radioactivity of 
reaction products left in the body as a result of such interactions.  In 
fact energetic gamma rays represent the most suitable probes. They 
penetrate tissue with only little interference, and they are relatively 
easy to measure.  Particle-therapy PET appears an obvious solution to 
the range assessment problem.  Various positron emitters are 
produced in beam-tissue interactions, and their spatial distribution 
can be imaged with established equipment (i.e., commercial PET 
scanners) just after the treatment.  However, this technique suffers 
from an asynchronism between the initial beam interaction and the 
delayed annihilation signature deployed for imaging.  Washout effects 
degrade the spatial correlation between dose deposition and signal, 
thus fundamentally limiting the accuracy of the method.  Moreover, 
the signal relaxation time, given by the decay time constants of the 
positron emitters, excludes any use for real-time treatment control.  
That is why many efforts have been focused on the exploration and 
development of imaging systems for the energetic prompt gamma 
radiation produced by the treatment beam.  Two basic concepts of 
Prompt Gamma-Ray Imaging (PGI) have been considered so 
far: Pinhole or slit cameras, and Compton-imaging systems.  The talk 
will review some of the advanced projects pursued by various research 
groups, which are based on very different detector concepts, and 
discuss the potential impact of PGI on the clinical workflow. 
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Proton computed tomography (pCT) was first investigated in the1970s 
at the Lawrence Berkeley and Los Alamos National Laboratories after 
earlier studies with proton radiography at the Harvard Cyclotron 
Laboratory had yielded promising results. The time appears ready to 
bring this advanced imaging technology, which utilizes the proton 
beam itself, into the treatment room for improved range prediction of 
proton and ion beams. The purpose of this presentation is to give an 
update on the pCT detector and image reconstruction developments 
on behalf of the pCT Collaboration. The first pCT scanner design, 
completed in 2010, consists of upstream and downstream trackers of 9 
cm x 18 cm area that register locations and directions of in- and 
outgoing protons on a particle-by-particles basis. The outgoing protons 
are stopped in a segmented crystal calorimeter. The calorimeter 
response is directly calibrated against water-equivalent path length as 
described previously [2]. The system readout is based on the 
application-specific integrated circuit (ASIC) built for the Fermi-LAT 
Space Telescope. The next generation of pCT scanner increases the 
sensitive area to 9 cm x 18 cm and features a multi-stage 
energy/range detector comprised of five plastic scintillators. A new 
ASIC, specifically designed for the system, will allow proton rates 
exceeding 1 MHz. 
Initial objects scanned with the first-generation scanner included a 
uniform water phantom, a spherical polystyrene phantom with bone 
equivalent and acrylic inserts, and a pediatric head phantom. 3D 
image data sets were generated with an iterative reconstruction 
method utilizing the most likely path concept [3]. The reconstruction 
code was executed on a single GPU, taking 2-3 hours for 10 iterations. 
Reconstructed relative stopping power values for acrylic, polystyrene, 
and bone equivalent were found to be within 1% of predicted values. 
While the first-generation pCT scanner has shown promising 
performance, it is not suitable for clinical application due to 
insufficient detection area and long data acquisition and 
reconstruction times. This will be further improved in the next 
generation of pCT, which will allow data acquisition and 
reconstruction in less than 10 minutes.  Once fully developed, proton 
CT can provide more accurate RSP values for improved range 
prediction. Additional information on average atomic composition may 
be possible by reconstructing local proton scattering power (RScP). 
RSP and RScP maps will then provide data for Monte Carlo based 
treatment planning simulations, which will be more accurate than 
currently possible with x-ray CT-based planning data. The use of the 
primary beam modality (protons) for in-room imaging is also attractive 
for the development for adaptive proton or ion therapy. In this 
application, pCT would be used to provide an updated RSP map just 
before treatment which would be used to calculate an updated 
“treatment plan of the day.” Additional future applications of this 
promising technology will be presented and discussed.   
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